Agios Pharmaceuticals, Inc. (AGIO) vs Sarepta Therapeutics, Inc. (SRPT)
- Agios Pharmaceuticals, Inc. AGIO 31.32 −3.09%
- Sarepta Therapeutics, Inc. SRPT 17.06 −4.10%
Agios Pharmaceuticals, Inc. and Sarepta Therapeutics, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Sarepta Therapeutics, Inc. are of similar size ($1.9B and $1.9B). Agios Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 140.6% against −20.4%. Sarepta Therapeutics, Inc. has the higher net margin (−6.93% vs −418.2%) and the higher return on invested capital (−5.64% vs −70.2%). Across the 18 metrics below, Sarepta Therapeutics, Inc. leads on 13 and Agios Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | AGIO | SRPT | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.99% | 59.09% | 65.16% |
| Operating margin | (466.78%) | (7.26%) | 0.00% |
| Net margin | (418.24%) | (6.93%) | 0.00% |
| Free cash flow margin | (371.43%) | 3.80% | 0.00% |
| Return on equity | (34.34%) | (9.48%) | (56.36%) |
| Return on assets | (31.89%) | (3.98%) | (48.04%) |
| Return on invested capital | (70.24%) | (5.64%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack